BCR-ABL tyrosine kinase inhibitors

Pfizer 500 Pill - red oval

Generic Name: bosutinib

Pill with imprint Pfizer 500 is Red, Oval and has been identified as Bosulif 500 mg. It is supplied by Pfizer Inc.

Bosulif is used in the treatment of Chronic Myelogenous Leukemia and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Bosulif 500 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Bosulif (Bosutinib [ boe-sue-tin-ib ])-Pfizer 500-500 mg-Red-Oval
Bosulif (Bosutinib [ boe-sue-tin-ib ])-Pfizer 500-500 mg-Red-Oval

Bosulif
Generic Name: bosutinib [ boe-sue-tin-ib ]
Imprint: Pfizer 500
Strength: 500 mg
Color: Red
Size: N/A
Shape: Oval
Availability: Prescription only
Drug Class: BCR-ABL tyrosine kinase inhibitors
Pregnancy Category: D - Positive evidence of risk
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 00069-0136
Inactive Ingredients: Microcrystalline cellulose, Croscarmellose sodium, Povidone k25, Magnesium stearate, Titanium dioxide, Polyethylene glycol 3350, Magnesium silicate, Ferric oxide red, Poloxamer 188,
Latest News
Related Drugs